Sanos Group Company Profile
Background
Overview
Sanos Group is a global Contract Research Organization (CRO) specializing in clinical trials for musculoskeletal disorders, neurological conditions, and dermatological diseases. Established in Denmark, the company offers comprehensive services encompassing patient recruitment, research clinics, clinical trial supply, electronic clinical outcome assessments (eCOA), and data science.
Mission and Vision
Sanos Group is dedicated to advancing medical research by delivering high-quality clinical trials that expedite the development of new treatments. The company's mission is to improve patient outcomes through scientific excellence and operational efficiency.
Primary Area of Focus
The company focuses on conducting specialized clinical trials in three key therapeutic areas:
- Musculoskeletal and Related Disorders: Through its division NBCD, Sanos Group leads research in musculoskeletal diseases, aiming to enhance patient recruitment and data quality.
- Neurological Disorders: Under the division Neuroscios, the company specializes in clinical research for neurological conditions, with a particular emphasis on central nervous system diseases and Alzheimer's.
- Dermatological Conditions: Blueskin, another division, is dedicated to clinical research in dermatology, ensuring the safety and efficacy of novel skin therapies.
Industry Significance
Sanos Group plays a critical role in the pharmaceutical and biotechnology industries by providing specialized clinical trial services that accelerate the development of new medications and treatments. Its expertise in niche therapeutic areas and integrated service offerings make it a valuable partner for global research organizations.
Key Strategic Focus
Core Objectives
- Expansion of Therapeutic Areas: Sanos Group aims to broaden its clinical trial services beyond its current focus areas to include other therapeutic domains, thereby increasing its market reach.
- Geographical Expansion: The company plans to extend its network of research clinics into new regions, including the United States and other European countries, to enhance its global presence.
Specific Areas of Specialization
- Patient Recruitment: Utilizing digital strategies and advanced analytics, Sanos Group optimizes patient enrollment, reducing recruitment timelines and improving participant retention.
- Research Clinics: With a network of dedicated research clinics, the company ensures high-quality trial execution, prioritizing data integrity and patient well-being.
- Clinical Trial Supply: Sanos Group offers end-to-end logistics, including manufacturing, packaging, labeling, and distribution, to streamline the clinical trial process.
Key Technologies Utilized
- Electronic Clinical Outcome Assessments (eCOA): The company delivers validated eCOA solutions that ensure accurate, timely data collection with minimal participant burden.
- Data Science: Sanos Group applies cutting-edge statistical methodologies to enhance trial precision, from study design to final reporting.
Primary Markets or Conditions Targeted
The company's primary markets include pharmaceutical and biotechnology companies seeking specialized clinical trial services in musculoskeletal, neurological, and dermatological conditions.
Financials and Funding
Funding History
Sanos Group has undergone significant financial developments:
- Acquisition by Investcorp: In December 2020, Investcorp, a global provider of alternative investment products, acquired Sanos Group. This acquisition aimed to support the company's expansion into new therapeutic areas and geographical regions.
Total Funds Raised
Specific details regarding the total funds raised by Sanos Group are not publicly disclosed.
Notable Investors
Investcorp is a notable investor in Sanos Group, having acquired the company in 2020.
Intended Utilization of Capital
The capital from Investcorp's acquisition is intended to:
- Expand Therapeutic Areas: Develop clinical trials in additional therapeutic domains.
- Geographical Expansion: Establish new research clinics in the U.S. and other European countries.
Pipeline Development
Key Pipeline Candidates
Sanos Group's pipeline includes:
- Musculoskeletal Disorders: Clinical trials focusing on conditions such as osteoarthritis.
- Neurological Disorders: Research targeting central nervous system diseases and Alzheimer's.
- Dermatological Conditions: Studies on novel skin therapies.
Stages of Clinical Trials or Product Development
The company conducts clinical trials at various stages, from early-phase studies to late-phase trials, depending on the specific therapeutic area and client requirements.
Target Conditions
Sanos Group targets conditions including:
- Musculoskeletal: Osteoarthritis and related disorders.
- Neurological: Alzheimer's disease and other central nervous system conditions.
- Dermatological: Various skin diseases.
Relevant Timelines for Anticipated Milestones
Specific timelines for clinical trial milestones are not publicly disclosed.
Technological Platform and Innovation
Proprietary Technologies
Sanos Group utilizes proprietary technologies in:
- eCOA Solutions: Ensuring accurate and timely data collection.
- Data Science: Applying advanced statistical methodologies to optimize clinical trial design and data analysis.
Leadership Team
Sanos Group’s leadership team comprises experienced professionals with deep expertise in clinical research, business development, and operational management. Their combined experience drives the company's commitment to scientific rigor and client satisfaction across all therapeutic areas and service offerings.
